ASPN on NYSE

ASPEN AEROGELS INC

ASPEN AEROGELS INC is an American wholesale-lumber and construction materials company.1 It is headquartered in Northborough, Massachusetts.1 Its shares trade on NYSE under the symbol ASPN.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Capstone Holding Corp., SMJ International Holdings Inc. or BOISE CASCADE Co, or pick any stock.

  • TickerASPN on NYSE1
  • IndustryWholesale-Lumber & Other Construction Materials1
  • HeadquartersNorthborough, Massachusetts1
  • Incorporated inDE2
  • Business address30 Forbes Road, Building B, Northborough, Ma 015322
  • Filer categoryAccelerated filer2
  • Legal formCorporation

When used in this report, the terms “we,” “us,” “our” and “the Company” refer to Aspen Aerogels, Inc. and its subsidiaries. Additionally, we do not use the ® or ™ symbol in each instance in which one of our trademarks appears in this report, but this should not be construed as any indication that we will not assert our rights thereto to the fullest extent under applicable law.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

17.0%Gross margin4
-139.5%Operating margin4
-143.7%Net margin4
-40.1%Revenue growth, 20254
-165.4%Return on equity4
0.28×Debt to equity4
-$4.6MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Thermal Barrier brought in 62% of the revenue ASPEN AEROGELS INC broke down this way in fiscal 2025.

  1. Thermal Barrier$168.9M462%down 45% from 2024
  2. Energy Industrial$102.2M438%down 30% from 2024
Products and services by year
Products and services202320242025
Thermal Barrier$110.1M$306.8M$168.9M
Energy Industrial$128.6M$145.9M$102.2M

Business segments

Thermal Barrier brought in 62% of the revenue ASPEN AEROGELS INC broke down this way in fiscal 2025.

  1. Thermal Barrier$168.9M462%down 45% from 2024
  2. Energy Industrial$102.2M438%down 30% from 2024
Business segments by year
Business segments202320242025
Thermal Barrier$110.1M$306.8M$168.9M
Energy Industrial$128.6M$145.9M$102.2M

Regions

United States brought in 63% of the revenue ASPEN AEROGELS INC broke down this way in fiscal 2025.

  1. United States$172.1M463%down 33% from 2024
  2. Latin America$47.6M418%down 53% from 2024
  3. Asia$31.1M411%up 6% from 2024
  4. Europe$17.9M47%down 60% from 2024
  5. CA [member]$2.5M41%down 87% from 2024
Regions by year
Regions202320242025
United States$151.0M$258.5M$172.1M
Latin America$7.2M$100.6M$47.6M
Asia$35.7M$29.3M$31.1M
Europe$42.7M$45.0M$17.9M
CA [member]$2.0M$19.3M$2.5M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue83¢$225.1M
  • Research and development5¢$13.4M
  • Other costs11¢$30.2M
  • Income tax1¢$2.4M

Out of $271.1M in revenue.4 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending100¢$37.4M

Out of $32.9M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4

Financial statements

Revenue56784$271.1M in 2025+95% since 2019
0$200.0M$400.0M$600.0M2019: $139.4M$139.4M20192020: $100.3M$100.3M2020−28%2021: $121.6M$121.6M2021+21%2022: $180.4M$180.4M2022+48%2023: $238.7M$238.7M2023+32%2024: $452.7M$452.7M2024+90%2025: $271.1M$271.1M2025−40%
Gross profit56784$46.0M in 2025+75% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $26.3M$26.3M20192020: $14.6M$14.6M2020−44%2021: $9.9M$9.9M2021−32%2022: $5.0M$5.0M2022−50%2023: $56.9M$56.9M2023+1044%2024: $182.9M$182.9M2024+221%2025: $46.0M$46.0M2025−75%
Operating income56784-$378.2M in 2025+2571% since 2019
-$400.0M-$200.0M0$200.0M2019: -$14.2M-$14.2M20192020: -$21.6M-$21.6M2020+52%2021: -$40.6M-$40.6M2021+88%2022: -$79.2M-$79.2M2022+95%2023: -$49.2M-$49.2M2023−38%2024: $54.5M$54.5M20242025: -$378.2M-$378.2M2025
Net income56784-$389.6M in 2025+2575% since 2019
-$400.0M-$200.0M0$200.0M2019: -$14.6M-$14.6M20192020: -$21.8M-$21.8M2020+50%2021: -$37.1M-$37.1M2021+70%2022: -$82.7M-$82.7M2022+123%2023: -$45.8M-$45.8M2023−45%2024: $13.4M$13.4M20242025: -$389.6M-$389.6M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Revenue$271.1M$452.7M$238.7M
Cost of revenue$225.1M$269.8M$181.8M
Gross profit$46.0M$182.9M$56.9M
Research and development$13.4M$18.1M$16.4M
Sales and marketing$28.2M$35.7M$33.0M
General and administrative$55.8M$71.1M$56.8M
Restructuring and demobilization costs$17.5M
Loss on disposal of property, plant and equipment$18.2M
Impairment of property, plant and equipment$291.2M$3.5M
Total operating expenses$424.2M$128.4M$106.1M
Income (loss) from operations-$378.2M$54.5M-$49.2M
Interest expense, convertible note - related party-$7.5M-$5.3M
Interest income (expense), net-$10.7M-$4.4M$6.5M
Income from Employee Retention Credits$2.2M
Loss on extinguishment of debt-$27.5M
Other income$1.8M
Total other income (expense)-$8.9M-$39.4M$3.4M
Income (loss) before income tax expense-$387.2M$15.1M-$45.8M
Income tax expense-$2.4M-$1.7M$0
Net income (loss)-$389.6M$13.4M-$45.8M
Basic-$4.73$0.17-$0.66
Diluted-$4.73$0.17-$0.66
Basic82.3M shares77.5M shares69.4M shares
Diluted82.3M shares80.3M shares69.4M shares

Compare ASPEN AEROGELS INC with another company

Corporate structure

ASPEN AEROGELS INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of ASPEN AEROGELS INC

  • ASPEN AEROGELS INC Northborough, Massachusetts

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What ASPEN AEROGELS INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$294.2M4 Dec 31, 2025$616.0M4 Dec 31, 2024−52.2%
Accumulated depreciation$195.8M4 Dec 31, 2025$156.7M4 Dec 31, 2024+24.9%
Property and equipment, net$98.4M4 Dec 31, 2025$459.3M4 Dec 31, 2024−78.6%
Finance-lease assets$6.1M4 Dec 31, 2025
Operating-lease assets (leased space)$18.0M4 Dec 31, 2025$20.9M4 Dec 31, 2024−13.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$156.9M4 Dec 31, 2025$220.9M4 Dec 31, 2024−29.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$38.2M4 Dec 31, 2025$47.6M4 Dec 31, 2024−19.6%
Raw materials$8.2M4 Dec 31, 2025$13.7M4 Dec 31, 2024−40.2%
Work in process$5.5M4 Dec 31, 2025$9.7M4 Dec 31, 2024−42.9%
Finished goods$24.5M4 Dec 31, 2025$24.2M4 Dec 31, 2024+1.4%

Properties, in its own words

Our corporate headquarters are located in Northborough, Massachusetts, where we occupy approximately 51,650 square feet under a lease expiring on December 31, 2031. We also own an approximately 148,000 square foot manufacturing facility in East Providence, Rhode Island. We lease additional spaces for research, administrative, manufacturing, and warehousing purposes in four

locations in the United States and two locations in Mexico under leases expiring between July 31, 2026 and April 30, 2034. The table below shows a summary of the square footage of these locations as of December 31, 2025:

The rest of Item 2

Leased Properties by Location

(In square ft.)

East Providence, RI · 196,969

Marlborough, MA · 58,965

Monterrey, MX · 266,381

Northborough, MA · 51,650

Statesboro, GA · 53,015

Item 2 of the 10-K filed Mar 13, 2026.3

Leadership

Who has led ASPEN AEROGELS INC, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (21)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive Officer, DirectorDonald R. Young named Mar 3, 2022 to Apr 6, 202237
  • Executive OfficerKeith R. Schilling named Mar 3, 2022 to Apr 6, 202237

Timeline

  1. Sep 15, 20268-K Regulation FD disclosure38
  2. Aug 6, 20268-K Results of operations; Regulation FD disclosure39
  3. May 18, 20268-K Executive or director change; Shareholder vote; Regulation FD disclosure40
  4. May 7, 20268-K Results of operations; Regulation FD disclosure41
  5. Apr 21, 20268-K Regulation FD disclosure; Other events42
  6. Feb 25, 20268-K Results of operations; Regulation FD disclosure43
  7. Dec 18, 20258-K Entered a material agreement; Regulation FD disclosure44
  8. Nov 6, 20258-K Results of operations; Regulation FD disclosure45
  9. Sep 11, 20258-K Executive or director change46
  10. Aug 7, 20258-K Results of operations; Regulation FD disclosure47
  11. May 8, 20258-K Results of operations; Regulation FD disclosure48
  12. May 1, 20258-K Executive or director change; Shareholder vote49

Calendar

Coming up

  1. Nov 5, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($0.06) a share, on Nov 6, 2025.50

When it reported results

  1. Aug 6, 2026Reported quarterly or annual results39
  2. May 7, 2026Reported quarterly or annual results41
  3. Feb 25, 2026Reported quarterly or annual results43
  4. Nov 6, 2025Reported quarterly or annual results45
  5. Aug 7, 2025Reported quarterly or annual results47
  6. May 8, 2025Reported quarterly or annual results48
  7. Feb 12, 2025Reported quarterly or annual results51
  8. Nov 6, 2024Reported quarterly or annual results52

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

379 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 72 major events, 201 insider forms, 26 large holders, 2 private raises, 57 other. The latest 20:

  1. Oct 1, 20264 EDGAR
  2. Sep 24, 2026SCHEDULE 13D/A EDGAR
  3. Sep 24, 20264 EDGAR
  4. Sep 15, 20268-K EDGAR
  5. Aug 13, 2026SCHEDULE 13G/A EDGAR
  6. Aug 10, 2026144 EDGAR
  7. Aug 7, 202610-Q EDGAR
  8. Aug 6, 20268-K EDGAR
  9. Jun 26, 20264 OWNERSHIP DOCUMENT EDGAR
  10. May 18, 20268-K EDGAR
  11. May 14, 20264 EDGAR
  12. May 14, 20264 EDGAR
  13. May 14, 20264 EDGAR
  14. May 14, 20264 EDGAR
  15. May 14, 20264 EDGAR
  16. May 8, 202610-Q EDGAR
  17. May 7, 20268-K EDGAR
  18. Apr 21, 20268-K EDGAR
  19. Mar 27, 2026ARS EDGAR
  20. Mar 27, 2026DEFA14A EDGAR

The 379 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

30 open-market trades by officers, directors and large owners since October 2021: 10 buys and 20 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 23, 2026Wood River Capital, LLCSale12,280,426$4.73$58.1MForm 4
Nov 13, 2025Young Donald RPresident and CEOSale56,845$3.23$183.6KForm 4
Aug 13, 2025Daniel Santhosh PChief Accounting OfficerSale2,000$7.54$15.1KForm 4
Aug 12, 2025Daniel Santhosh PChief Accounting OfficerSale4,410$7.31$32.2KForm 4
May 12, 2025Young Donald RPresident and CEOBuy20,000$5.35$107.0KForm 4
Sep 30, 2024Young Donald RPresident and CEOSale63,355$30.03$1.9MForm 4
Aug 26, 2024RODRIGUEZ RICARDO C.CFO & TreasurerSale32,465$30.14$978.4KForm 4
May 29, 2024Young Donald RPresident and CEOSale176,746$29.38$5.2MForm 4
May 28, 2024Young Donald RPresident and CEOSale256,944$29.24$7.5MForm 4
May 22, 2024Kool KathleenDirectorSale4,470$27.30$122.0KForm 4
May 14, 2024KOCH INDUSTRIES INCSale3,500,000$23.50$82.2MForm 4
May 13, 2024SCHILLING KEITH LSVP, TechnologySale20,000$26.84$536.9KForm 4
May 6, 2024Whitaker Corby CChief Commercial OfficerSale55,159$25.01$1.4MForm 4
May 6, 2024Landes GreggChief Operating OfficerSale48,386$25.39$1.2MForm 4
Nov 20, 2023Landes GreggChief Operating OfficerSale155$11.01$1.7KForm 4
Sep 7, 2023Mitchell Steven RDirectorBuy7,541$6.50$49.0KForm 4
Sep 5, 2023Mitchell Steven RDirectorBuy50,000$6.17$308.5KForm 4
Aug 22, 2023Noetzel Mark LDirectorBuy4,000$5.65$22.6KForm 4
Aug 8, 2023Young Donald RPresident and CEOBuy25,000$6.83$170.8KForm 4
Dec 6, 2022SWEETNAM JAMES EDirectorBuy2,700$11.30$30.5KForm 4

All 30 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025Donald R. Young68$577.1K$2.7M63
2025Ricardo C. Rodriguez$312.3K$2.5M63
2025Virginia H. Johnson$190.4K$1.9M63
2025Keith L. Schilling$192.3K$1.8M63
2025Corby C. Whitaker56$440.0K$1.4M63
2025Gregg R. Landes56$410.8K$1.4M63
2025Grant D. Thoele38$347.7K$943.3K63
2025Glenn E. Deegan59$106.2K$470.4K63
2024President and Chief ExecutiveOfficer$515.0K$3.1M63
2024Former Chief Legal OfficerGeneral Counsel and Corporate Secretary$450.0K$1.6M63
2024Chief Commercial Officer$429.2K$1.6M63
2024Chief Operating Officer$400.0K$1.5M63
2024Former Chief Financial Officerand Treasurer$400.0K$1.5M63
2023President and Chief ExecutiveOfficer$515.0K$3.6M63
2023Former Chief Legal OfficerGeneral Counsel and Corporate Secretary$450.0K$1.9M63
2023Chief Commercial Officer$400.0K$1.8M63
2023Chief Operating Officer$400.0K$1.8M63
2023Former Chief Financial Officerand Treasurer$386.5K$1.8M63

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Mar 28, 2022Raised $50 million in a private offering of equity Form D: 1 investor so far Form D
  2. Feb 18, 2022Raised $100 million in a private offering of debt Form D: 1 investor so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Kim, LLC12,280,426$77.9M22.2%No change
BlackRock, Inc.5,277,148$33.5M0.0%+534,072
Oaktop Capital Management Ii, L.P.5,168,674$32.8M1.4%No change
Vanguard Capital Management LLC3,539,271$22.4M0.0%+103,115
Needham Investment Management LLC3,260,800$20.7M0.6%−1,257,975
George Kaiser Family Foundation3,167,322$20.1M1.9%No change
State Street Corp2,559,495$16.2M0.0%+238,768
American Century Companies Inc2,510,042$15.9M0.0%+1,262,259
Jacobs Levy Equity Management, Inc2,058,083$13.0M0.0%+839,304
Ameriprise Financial Inc1,821,295$11.5M0.0%+314,916
Geode Capital Management, LLC1,770,425$11.2M0.0%+229,654
Rice Hall James & Associates, LLC1,635,259$10.4M0.5%+82,631
Invesco Ltd.1,619,972$10.3M0.0%−678,211
Gagnon Securities LLC1,535,812$9.7M1.9%−326,039
Dimensional Fund Advisors LP1,447,333$9.2M0.0%+190,853
Goldman Sachs Group Inc1,372,300$8.7M0.0%+472,787
Royce & Associates LP1,323,218$8.4M0.1%+336,705
Aqr Capital Management LLC1,276,346$8.1M0.0%+750,227
Millennium Management LLC1,190,616$7.5M0.0%−214,059
Marshall Wace, Llp1,146,707$7.3M0.0%−116,395
D. E. Shaw & Co., Inc.1,066,501$6.8M0.0%+232,929
Telemark Asset Management, LLC1,000,000$6.3M0.5%No change
Jpmorgan Chase & Co1,004,383$6.0M0.0%+38,891
Bnp Paribas Financial Markets867,199$5.5M0.0%+169,267
Two Sigma Investments, LP779,468$4.9M0.0%+338,032

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How ASPEN AEROGELS INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARASPEN AEROGELS INC1
  • CIK0001145986
  • Employer ID (EIN)04-35599723
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company3
  • Incorporated inDelaware3
  • Fiscal year endsDecember 311
  • Industry code (SIC)5030 Wholesale-Lumber & Other Construction Materials1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business address30 Forbes Road, Building B, Northborough, MA 015321
  • Phone50869111111
  • Shares outstanding82,988,784 as of Aug 4, 202610
  • Public float$480.0M as of Jun 30, 20253
  • AuditorKPMG LLP, Boston, MA, United States of America PCAOB ID 185; it also attests to the company’s internal control over financial reporting3
  • On EDGAR sinceFeb 5, 20021
  • Filings866 in all: 4 (410), 8-K (148), 10-Q (37), 3 (31), SC 13G/A (30), SC 13G (17), DEFA14A (15), 10-K (12)1
    All 46 form types

    DEF 14A (12), S-8 (12), 4/A (11), UPLOAD (11), 424B5 (10), CORRESP (10), 144 (9), D (8), EFFECT (8), S-1/A (8), SC 13D/A (8), REGDEX (6), S-3 (6), ARS (5), SCHEDULE 13G/A (5), REGDEX/A (4), CT ORDER (3), D/A (3), FWP (3), 424B3 (2), PRE 14A (2), S-1 (2), S-3ASR (2), SC 13D (2), 10-K/A (1), 3/A (1), 305B2 (1), 424B4 (1), 5 (1), 8-A12B (1), CERTNYS (1), DRS (1), POS AM (1), POSASR (1), RW (1), S-1MEF (1), SCHEDULE 13D/A (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Mar 13, 2026
    Quarterly report (10-Q) Aug 7, 2026
    Proxy statement (DEF 14A) Mar 27, 2026
    Latest 8-K (8-K) Sep 15, 2026

Securities registered for trading

ClassSymbolExchange
Common Stock, par value $0.00001 per shareASPNNew York Stock Exchange

From the cover page of the 10-K filed Mar 13, 2026 (Section 12(b) of the Exchange Act).3

Risk factors and legal proceedings

The risks ASPEN AEROGELS INC names in Item 1A of its 10-K filed Mar 13, 2026: 59 risks under these headings, as written.3

  • Risks Related to Our Business and Strategy
  • We previously incurred annual net losses, and we may incur net losses in the future and may never reach profitability.
  • We will require additional capital to pursue our growth strategy, but we may not be able to obtain additional financing on acceptable terms or at all.
  • While we achieved positive operating cash flows for the fiscal years ended December 31, 2025 and 2024, our ability to continue generating positive cash flow is uncertain.
  • Our ability to use our net operating loss carryforwards may be subject to limitation, which could result in a higher effective tax rate and adversely affect our financial condition and results of operations.
  • The terms of our Credit Agreement with MidCap require us to meet certain operating and financial covenants and/or place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our ability to operate our business.
  • Our efforts in developing, selling, and supplying products in the EV market may subject us to increased financial, operational, and legal risks that could materially adversely impact our business, financial conditions, and results of operations and may also increase our costs and make it difficult for us to operate profitably.
  • Our estimates regarding market opportunity for our products in the EV market and the assumptions on which our financial targets are based may prove to be inaccurate, which may cause our actual results to materially differ from such targets, which may adversely affect our future profitability, cash flows, and stock price.
  • Our working capital requirements involve estimates based on demand and production expectations and may decrease or increase beyond those currently anticipated, which could materially harm our results of operations and financial condition.
  • Automotive OEM Customer Relationship Risks
  • Our relationships with automotive OEM customers involve multiple interconnected risks that could materially adversely impact our business, revenues, and profitability. These risks include but are not limited to being party to contracts without minimum commitments, pricing pressures, and cost reduction initiatives, selection of cell chemistries, battery pack system architectures, and customer market share and production declines.
  • Our success in the EV market is dependent upon consumers’ willingness to purchase and use EVs and demand for EVs generally.
The other 49 risks
  • Failure by us to develop, maintain and strengthen strategic relationships with industry leaders to commercialize our products in the EV market may adversely affect our results of operations and our ability to grow our business.
  • We are currently dependent on a single manufacturing facility located in East Providence, RI, as well as our third-party external manufacturing facilities in China. Any significant disruption to these facilities or the failure of any one of our three production lines in our East Providence, RI facility to operate according to our expectation could have a material adverse effect on our business and results of operations.
  • We have engaged third-party external manufacturing facilities in China to supplement our supply of our aerogel products. Our reliance on these external manufacturing facilities subjects us to operational, quality, regulatory, and geopolitical risks that could disrupt our supply chain, harm our reputation, and adversely affect our business operations.
  • We may encounter manufacturing challenges in the EV market.
  • From time to time, we have had difficulty in consistently producing products that meet applicable product specifications and technical and delivery requirements, and such difficulties could expose us to financial, contractual, or other liabilities.
  • A substantial portion of our revenue comes from sales in foreign countries, and we are planning to further expand our operations outside of the United States, which subjects us to increased economic, trade, foreign exchange, operational, and political risks that could materially adversely impact our business, financial conditions and results of operations and also increase our costs and make it difficult for us to operate profitably.
  • Inadequate funding for the SEC and other government agencies, or a work slowdown or stoppage at those agencies as part of a broader federal government shutdown, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.
  • Changes in U.S. trade policy and the impact of tariffs may have a material adverse effect on our business, results of operations and financial condition. Changes in the U.S. regulatory framework may also impact EV demand, which could have a material adverse effect on our business, results of operations and financial condition.
  • Shortages of the raw materials used in the production of our products, increases in the cost of such materials or disruptions in our supply chain could have a material adverse impact on our financial condition and results of operations.
  • A sustained downturn in the energy industry, due to lower oil and gas prices or reduced energy demand, could decrease demand for some or all of our products and services, which could have a material adverse effect on our business, financial condition and results of operations.
  • The market for insulation products incorporating aerogel blankets is relatively undeveloped and our products may never be widely adopted, which would have a material adverse effect on our business.
  • Our products are expensive relative to other insulation products, which could make it more difficult for us to grow our revenue and achieve broader adoption of our aerogel products.
  • The insulation markets we serve are highly competitive. If we are unable to compete successfully, we may not be able to increase or maintain our market share and revenues.
  • We have entered into and may enter into future agreements that may limit our ability to broadly market our products or could involve future obligations, which could make it more difficult for us to commercialize certain of our products and negatively affect our business and results of operations.
  • We may not be able to successfully develop and introduce new products in a timely manner at competitive prices, which would limit our ability to grow and maintain our competitive position and could adversely affect our financial conditions, results of operations and cash flow.
  • If we do not continue to develop and maintain distribution channels for our products and to meet our customers’ demand for our products, our results of operations could be adversely affected.
  • The qualification process for our products can be lengthy and unpredictable, potentially delaying adoption of our products and causing us to incur significant expense potentially without recovery.
  • Our revenue may fluctuate, which may result in a high degree of variability in our results of operations and make it difficult for us to plan based on our future outlook and to forecast our future performance, and the results of our operations could be materially adversely affected if our operating expenses incurred do not correspond with the timing of our revenues.
  • We are exposed to the credit risk of some of our direct customers, including distributors, contractors and OEMs, which subjects us to the risk of non-payment for our products.
  • If we are unable to maintain our technological advantage over our competitors, our business may be materially adversely affected.
  • Negative perceptions regarding the safety, quality or other attributes of our products or a failure or a perceived failure of our products could have a material adverse effect on our results of operations and could make us unable to continue our business.
  • Trends in adoption of cathode chemistries may adversely affect the adoption of silicon-rich carbon aerogels that we are developing for use in anodes.
  • We or the third parties upon which we depend may be adversely affected by general political, unstable market and economic conditions and other events beyond our control and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.
  • Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults or non-performance by financial institutions or transactional counterparties, could adversely affect our current and projected business operations and our financial condition and results of operations.
  • Regulation of greenhouse gas emissions could reduce demand for hydrocarbon products and lead to a sustained downturn in the energy industry, which could decrease demand for our products and have a material adverse effect on our business, financial condition and results of operation.
  • Employee strikes and labor-related disruptions involving us or one or more of our automotive OEM customers or suppliers may adversely affect our operations.
  • If we lose key personnel upon whom we are dependent, or if we are unable to successfully recruit and retain skilled employees, we may not be able to manage our operations and meet our strategic objectives.
  • Because of our significant international operations, we could be materially adversely affected by violations of the U.S. FCPA and similar anti-corruption, anti-bribery, and anti-kickback laws.
  • A failure to comply with export control or economic sanctions laws and regulations could have a material adverse impact on our business, results of operations or financial condition. We may be unable to ensure that our distributors comply with applicable sanctions and export control laws.
  • Our activities and operations are subject to numerous health and safety laws and regulations. If we violate such regulations, we could face penalties and fines or be required to curtail or cease operations.
  • We may face certain product liability or warranty claims on our products, including from improper installation of our products by third parties. As a consequence, we could lose existing and future business and our ability to develop, market and sell our insulation could be harmed.
  • We may incur significant costs complying with environmental, health and safety laws, and related claims, and failure to comply with these laws and regulations could expose us to significant liabilities, which could materially adversely affect our results of operations.
  • Breakdowns, security breaches, loss of data, and other disruptions of our information technology systems could compromise sensitive information related to our business, prevent us from accessing critical information, and expose us to liability, which would cause our business and reputation to suffer.
  • Risks Related to Our Intellectual Property
  • Our inability to protect our intellectual property rights could negatively affect our business and results of operations.
  • Our potential inability to adequately protect our intellectual property as a result of engaging external manufacturing facilities in China for the supplemental supply of our aerogel products could negatively impact our performance.
  • We have in the past initiated intellectual property litigation and any future intellectual property litigation may be costly, and could limit or invalidate our intellectual property rights, divert time and efforts away from business operations, require us to pay damages and/or costs and expenses and/or otherwise have a material adverse impact on our business, and we could become subject to additional such intellectual property litigation in the future.
  • Patents covering technologies that are similar or superior to our technologies may be developed or obtained by third parties. We may need to seek licenses to these technologies, which could limit our ability to manufacture our products and have a material adverse effect on our business and results of operations.
  • Our contracts with third parties could negatively affect our intellectual property rights.
  • We rely on trade secrets to protect our technology, and our failure to obtain or maintain trade secret protection could materially adversely affect our competitive business position.
  • Risks Related to Our Data Privacy and Other Personal Information
  • We may be subject to, or may in the future become subject to, U.S. federal and state, and foreign laws and regulations imposing obligations on how we collect, use, disclose, store, and process personal information. Our actual or perceived failure to comply with such obligations could result in liability or reputational harm and could harm our business. Ensuring compliance with such laws could also impair our efforts to maintain and expand our customer base, and thereby decrease our revenue.
  • Risks Related to Our Common Stock
  • We have incurred and will continue to incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies in the United States, which may adversely affect our results of operations.
  • Because we are a public company, we are obligated to develop and maintain proper and effective internal control over financial reporting. If our internal controls over financial reporting are determined to be ineffective, or if our auditors are otherwise unable to attest to their effectiveness, investor confidence in our company, and our common stock price, may be adversely affected.
  • The trading market in our common stock has been limited and substantially less liquid than the average trading market for a stock quoted on The New York Stock Exchange.
  • We expect that the price of our common stock will continue to fluctuate substantially, which could subject us to securities class action litigation and result in substantial losses to our stockholders.
  • Securities analysts may not continue coverage of our common stock or may issue negative reports, which may have a negative impact on the market price of our common stock.
  • Anti-takeover provisions in our Certificate of Incorporation and restated bylaws, and Delaware law, could delay or discourage a takeover.
  • Our restated certificate of incorporation designates a state or federal court located within the State of Delaware as the exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
  • Our stockholders may experience future dilution as a result of future equity offerings.
  • We do not intend to pay cash dividends in the foreseeable future and, consequently, our stockholders’ ability to achieve a return on their investment will depend on appreciation in the price of our common stock.

Legal proceedings

Patent Enforcement Actions Initiated by Aspen

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63